• About us
• Contact

Advertisement

Product › Details

muscarinic M4 receptor agonist

	Next higher product group	CNS drug (neurological drug)

Record changed: 2023-07-10

Advertisement

More documents for CNS drug (neurological drug)

• [1] H. Lundbeck A/S. (6/3/26). "Press Release: Lundbeck Partners with Cradle to Discover and Optimize Brain Disorder Treatments". Valby & Amsterdam....
• [2] Tibeay Biosciences B.V.. (4/15/26). "Press Release: Tibeay Biosciences Raises EUR 35 Million for a Phase 3b Trial of Ronopterin in Traumatic Brain Injury". Nijmegen....
• [3] Biognosys Group. (4/14/26). "Press Release: Biognosys Group Announces Collaboration with The Michael J. Fox Foundation to Advance Parkinson’s Disease Research Through the Development of Improved Biomarker Assays". Zürich....
• [4] Eli Lilly and Company. (3/31/26). "Press Release: Lilly to Acquire Centessa Pharmaceuticals to Advance Treatments for Sleep-wake Disorders". Indianapolis, IN, Boston, MA & London....
• [5] Newron Pharmaceuticals S.p.A.. (2/16/26). "Press Release: Newron Secures up to EUR 38 Million to Advance Phase III Evenamide Program (Ad hoc announcement pursuant to Art. 53 LR)". Milan & Morristown, NJ....
• [6] Newron Pharmaceuticals S.p.A.. (1/7/26). "Press Release: EA Pharma, a Subsidiary of Eisai, Announces the Initiation of Its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan". Milan & Morristown, NJ....
• [7] Algiax Pharmaceuticals GmbH. (12/18/25). "Press Release: Algiax Appoints Dr. Daniel Gau as Chief Business Officer". Düsseldorf....
• [8] Syremis Therapeutics Ltd.. (12/18/25). "Press Release: Syremis Therapeutics Launches with $165M to Develop Best-in-Class Medicines for Mental Health Conditions". Tel Aviv & Boston, MA....
• [9] Atai Beckley N.V.. (11/5/25). "Press Release: Atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies". New York, NY & Amste...
• [10] H. Lundbeck A/S. (10/27/25). "Press Release: Lundbeck and OpenAI Join Forces to Unlock Innovation and Boost Productivity". Valby....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2026. Made in Germany.